Due to health issues, this site is no longer maintained and will be shut down shortly. |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
$1.65 +0.11 (7.14%)
As of 03/27/2023 10:43:48 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.